Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Minimum Dose CT Post Lung Biopsy Predict Patient Outcome?

NCT00188162 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT00188162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00188162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Minimum Dose CT Post Lung Biopsy Predict Patient Outcome?
Lead sponsor
University Health Network, Toronto
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2004
Completion date
September 30, 2005
Enrollment
100
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer